Dispatches from a Pandemic: The expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009%
‘It’s the same perceptual problem when we blindly drive to the airport texting, yet worry about the airplane.’.....»»
Dispatches from a Pandemic: The expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009%
‘It’s the same perceptual problem when we blindly drive to the airport texting, yet worry about the airplane.’.....»»
Dispatches from a Pandemic: ‘It was a wise decision to spread the risk’: Johnson & Johnson saga reveals vulnerabilities in COVID-19 vaccine strategy
“It’s still a race between the variants and the vaccine,” said Amesh Adalja, a senior scholar at the John Hopkins Center for Health Security......»»
Dispatches from a Pandemic: ‘It was a wise decision to spread the risk’: What Johnson & Johnson saga reveals about COVID-19 vaccination campaign
“It’s still a race between the variants and the vaccine,” said Amesh Adalja, a senior scholar at the John Hopkins Center for Health Security......»»
Johnson & Johnson Rises on 1st-Quarter Earnings Beat
Company reports solid Covid-19 vaccine sales despite blood clot issuesRelated Stocks: JNJ,.....»»
Johnson & Johnson asked other drugmakers to help it study blood-clot risks, and Moderna and Pfizer refused, report says
J&J privately contacted rival drugmakers also producing COVID-19 vaccines to join the study, and only AstraZeneca agreed, WSJ reports. Johnson & Johnson privately contacted other drugmakers producing COVID-19 vaccine to join a study into the p.....»»
Dispatches from a Pandemic: Johnson & Johnson and AstraZeneca sagas illustrate strength of COVID-19 strategy: ‘It was a wise decision to spread the risk’
‘Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’.....»»
Dispatches from a Pandemic: What Johnson & Johnson and AstraZeneca’s problems reveal about the COVID-19 mass-vaccination campaign
‘It was a wise decision to spread the risk. Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’.....»»
Dispatches from a Pandemic: Johnson & Johnson and AstraZeneca problems are not unexpected — it would be more unusual to have NO vaccine problems
‘It was a wise decision to spread the risk. Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’.....»»
Will the pause of Johnson & Johnson"s Covid-19 vaccine cause Arizona employers to back off vaccine mandates?
Will employers slow their efforts to mandate the Covid-19 vaccine at a time when one vaccine is being halted amid blood clot concerns? Here's what experts in Arizona are saying......»»
The US is pausing the Johnson & Johnson coronavirus vaccine rollout, citing the risk of rare blood clots
The US will stop distributing the Johnson & Johnson vaccine temporarily while federal agencies investigate a potential link to blood clots. A nurse loading a syringe with a dose of Johnson & Johnson's COVID-19 vacc.....»»
The Margin: Johnson & Johnson vaccine pause: What to know if you got or scheduled the shot
A CDC advisory committee recommends lifting the pause. So what blood clot symptoms should you watch out for if you get the vaccine?.....»»
The US is resuming its rollout of Johnson & Johnson"s vaccine after a pause to investigate blood clots
The COVID-19 shot will now come with a warn.....»»
CDC panel says Johnson & Johnson"s COVID-19 shot can be used again
Rare but potentially fatal blood clot.....»»
: J&J resumes European COVID-19 vaccine rollout with regulator-mandated safety warning
The European Medicines Agency demanded that a “warning about unusual blood clots with low blood platelets” be included in the product information of the Johnson & Johnson COVID-19 shots......»»
Johnson & Johnson jumps as vaccine shipments to Europe set to resume after regulator says benefits outweigh blood clot risks
Johnson & Johnso.....»»
Johnson & Johnson coronavirus vaccine should have warning labels about rare blood clots, but benefits outweigh risk, European agency says
The European Medicines Agency said these rare blood disorders should be considered as “very rare side effects of the vaccine.”The European Medicines Agency said these rare blood disorders should be considered as “very rare side effects of the vaccine.”.....»»
Johnson & Johnson vaccine should get blood-clot warning, European agency says
The European Medicines Agency said its safety committee concl.....»»
US officials may need 2 weeks or more to determine if Johnson & Johnson"s vaccine causes rare blood clots
The CDC still might not have enough data to evaluate a blood clot link by its Friday meeting, two senior health officials told Poli.....»»
Dispatches from a Pandemic: Mass vaccination was never expected to go perfectly — or provide 100% protection against COVID-19
Health professionals say the Johnson & Johnson and AstraZeneca sagas, reports of vaccinated people catching the virus, and other risks are built into the entire process......»»
The AstraZeneca and J&J vaccines share the same technology. It could explain why both have possible links to rare blood clots.
The AstraZeneca and Johnson & Johnson shots are both viral vector vaccines. Both have been linked to cases of rare blood clots in the brain. Nurse Elizabeth Johnson administers a COVID-19 vaccine to Melissa Mendez in Readin.....»»